Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-12

Clinical Trial Update: Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as A Part of Bismuth Based Quadruple Therapy for Treatment of Helicobacter Pylori Infection [NA]

View source ↗

Summary

A clinical trial is comparing potassium-competitive acid blockers with proton pump inhibitors as part of a bismuth-based quadruple regimen for Helicobacter pylo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Potassium-Competitive Acid Blocker (potassium-competitive acid blocker)
  • Proton Pump Inhibitor (proton pump inhibitor)

Snippet

Sponsor: Tanta University | Conditions: Potassium-Competitive Acid Blocker, Proton Pump Inhibitor | NA | Status: RECRUITING